Effects of IL-17 on erythroid progenitors growth: Involvement of MAPKs and GATA transcription factors

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 4, 2012, Pages 641-652

  Krstić, Aleksandra ^a   Kocic J ^a   Ilic V ^a   Mojsilovic S ^a   Okic Dordevic I ^a   Trivanovic D ^a   Santibanez J F ^a   Jovcic G ^a   Bugarski, D ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Erythropoiesis; GATA; IL 17; MAPK

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BURST FORMING UNIT E; COLONY FORMING UNIT E; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; WESTERN BLOTTING; ANIMAL; CBA MOUSE; CELL PROLIFERATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; ERYTHROID PRECURSOR CELLS; GATA TRANSCRIPTION FACTORS; INTERLEUKIN-17; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED CBA;

EID: 84876461901     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Geest CR, Coffer PJ. MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol 2009; 86:237-50.
2. Ingley E, Tilbrook PA, Klinken SP. New insights into the regulation of erythroid cells. IUBMB Life 2004; 56:177-84. (Pubitemid 38828745)
3. Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 2002; 21:3368-76. (Pubitemid 34587709)
4. Kluger Y, Lian Z, Zhang X, Newburger PE, Weissman SM. A panorama of lineage-specific transcription in hematopoiesis. BioEssays 2004; 26:1276-87. (Pubitemid 39664621)
5. Kerenyi MA, Orkin SH. Networking erythropoiesis. J Exp Med 2010. 207:2537-41.
6. Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. IL-17 cytokine family. J Allergy Clin Immunol 2004;114:1265-73. (Pubitemid 39585195)
7. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007; 19:281-86. (Pubitemid 46687011)
8. Schwarzenberger P, La Russa V, Miller A, et al. IL-17 stimulates granulopoiesis in mice: use of an alternate,novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 1998; 161:6383-89. (Pubitemid 28536015)
9. Forlow SB, Schurr JR, Kolls JK, Pagby GJ, Schwarzenberger PO, Ley K. Increased granulopoiesis through interleukin-17 and granulocyte-colony- stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 2001; 98:3309-14.
10. Jovčić G, Bugarski D, Petakov M, Krstić A, Vlaški M, Stojanović N, Milenković P. In vivo effects of interleukin-17 on haematopoietic cells and cytokine release in normal mice. Cell Prolif 2004; 37:401-12. (Pubitemid 39582791)
11. Krstić A, Ilić V, Mojsilović S, Jovčić G, Milenković P, Bugarski D. MAPK signaling mediates IL-17-induced nitric oxide synthase expression in bone marrow cells. Growth Factors 2009; 27:79-90.
12. Bugarski D, Krstic A, Mojsilovic S, et al. Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation. Exp Biol Med (Maywood) 2007; 232:156-63. (Pubitemid 46089950)
13. Towatari M, Ciro M, Ottolenghi S, Tsuzuki 5, Enver T. Involvement of mitogen-activated protein kinase in the cytokine-regulated phosphorylation of transcription factor GATA-1. Hematol J 2004; 5:262-72. (Pubitemid 38931333)
14. Towatari M, May GE, Marais R, Perkins GR, Marshall CJ, Cowley S, Enver T. Regulation of GATA-2 phosphorylation by mitogen-activated protein kinase and interleukin-3. J Biol Chem 1995; 270:4101-07.
15. Nagata Y, Nishida E, Todokoro K. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 1997; 89:2664-69. (Pubitemid 27172550)
16. Foltz IN, Schrader JW. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 1997; 89:3092-96. (Pubitemid 27229790)
17. Jacobs-Helber SM, Ryan JJ, Sawyer ST. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells. Blood 2000; 96:933-40. (Pubitemid 30616857)
18. Jacobs-Helber SM, Sawyer ST. Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines. Blood 2004; 104:696-703. (Pubitemid 38970562)
19. Witt O, Sand K, Pekrun A. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 2000; 95:2391-96. (Pubitemid 30167741)
20. Guihard S, Clay D, Cocault L, et al. The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis. Blood 2010; 115:3686-94.
21. Rubiolo C, Piazzolla D, Meissl K, Beug H, Huber JC, Kolbus A, Baccarini M. A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation. Blood 2006; 108:152-9. (Pubitemid 43990623)
22. Scicchitano MS, McFarland DC, Tierney LA, Boyce RW, Frazier KS, Schwartz LW, Thomas HC. Role of p38 in regulation of hematopoiesis: effect of p38 inhibition on cytokine production and transcription factor activity in human bone marrow stromal cells. Blood Cells Mol Dis 2008; 40: 370-80.
23. Ferreira R., Ohneda K., Yamamoto M, Philipsen S. GATA1 function: A paradigm for transcription factors in hematopoiesis. Mol Cell Biol 2005; 25:1215-27. (Pubitemid 40204902)
24. Suzuki N, Suwabe N, Ohneda O, Obara N, Imagawa S, Pan X, Motohashi H, Yamamoto M. Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels. Blood 2003;102:3575-83. (Pubitemid 37409373)
25. Zhao W, Kitidis C, Fleming MD, Lodish HF, Ghaffari S. Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway. Blood 2006; 107:907-15. (Pubitemid 43158401)
26. Buck I, Morceau F, Cristofanon S, Heintz C, Chateauvieux S, Reuter S, Dicato M, Diederich M. Tumor necrosis factor a inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation. Biochem Pharmacol 200;8. 76:1229-39.
27. Whyatt DJ, Karis A, Harkes IC, The level of the tissue-specific factor GATA-1 affects the cell-cycle machinery. Genes Funct 1997; 1:11-24.
28. Whyatt D, Lindeboom F, Karis A, Ferreira R, Milot E, Hendriks R, de Bruijn M, Langeveld A, Gribnau J, Grosveld F, Philipsen S. An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells. Nature 2000; 406:519-24. (Pubitemid 30625736)
29. Suzuki M, Moriguchi T, Ohneda K, Yamamoto M. Differential Contribution of the Gata1 Gene Hematopoietic Enhancer to Erythroid Differentiation. Mol Cell Biol 2009; 29:1163-75.
30. Hernandez-Hernandez A, Ray P, Litos G, Ciro M, Ottolenghi S, Beug H, Boyes J. Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1. EMBO J 2006; 25:3264-74. (Pubitemid 44141785)
31. Dalmas DA, Tierney LA, Zhang C, Narayanan PK, Boyce RW, Schwartz LW, Frazier KS, Scicchitano MS. Effects of p38 MAP kinase inhibitors on the differentiation and maturation of erythroid progenitors. Toxicol Pathol 2008; 36:958-71.
32. Pope SH, Fibach E, Sun J, Chin K, Rodgers GP. Two-phase liquid culture system models normal human adult erythropoiesis at the molecular level. Eur J Haematol 2000; 64:292-303. (Pubitemid 30307701)